Specialty Healthcare Benefits Council
On behalf of the Pharmacy and Therapeutics Society, I would
like to announce an organizational change to: Specialty
Healthcare Benefits Council.
As the development of specialty health products and services increase we see the parallel need for responsible accountability. We seek to ensure utilization is appropriate and clinically sound. By bringing together the community of stakeholders we look to provide pathways to allow sustainable use of these products. With evolution of this process we seek to define future benefit options, distribution systems and management tools to weave together the benefit systems that deliver a product to the right patient at the right time. Effective use of specialty health products and services occur only when value is clear and consistent with scientific evidence. We seek value through the balance of cost, access and quality. As a non-profit organization we provide a forum for collaboration among payers, developers, vendors and supporters in this dynamic marketplace.
Zach Gerger, D.O., PharmD
Announcing a new CE program on improving the cost
effective management of hemophilia in a managed care settting!
Coming soon. You may also view the 2014 Hemophilia Webcast modules with audio commentaries on the web site of the Partners in Bleeding and Thrombotic Disorders Education. You can then return here to complete the CE post-test. To access the webinar modules and audio commentaries,
You may also view the 2013 Hemophilia Webcast modules with audio commentaries on the web site of the Partners in Bleeding and Thrombotic Disorders Education. You can then return here to complete the CE post-test. To access the webinar modules and audio commentaries,
Implications of STeP for Improved Diabetes Control:
A Payer Perspective
The Specialty Healthcare Benefits Council (formerly the Pharmacy & Therapeutics Society) recently supported the above article on diabetes management that has been published in The American Journal of Pharmacy Benefits (AJPB).